Status:
COMPLETED
Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)
Lead Sponsor:
Pennington Biomedical Research Center
Collaborating Sponsors:
Nutrition Obesity Research Center
Conditions:
Insulin
Eligibility:
All Genders
45-65 years
Phase:
PHASE1
Brief Summary
The purpose of this research study is to investigate brain insulin's relationship with food intake in African Americans. Facilitating insulin's entrance into the brain through a nasal spray is current...
Detailed Description
The investigators will utilize a double-blind, placebo-controlled, randomized crossover design comparing a single acute dose of intranasal insulin to a single acute dose of a saline placebo. The prim...
Eligibility Criteria
Inclusion
- self-identify as African American
- are aged 45 years to 65 years old
- are willing to provide written informed consent
- speak and read English
Exclusion
- diagnosed with type 1 or 2 diabetes
- pregnant or attempting to become pregnant
- have a history of sensitivity to glutaraldehyde
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04739371
Start Date
June 17 2021
End Date
June 7 2022
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808